Concepedia

Madeline G. Huey

MG

Statistics

Publications

6

Citations

326

H-Index

6

Active since

2014

Affiliations

University of North Carolina at Chapel Hill(Current)

Emory University

Children's Healthcare of Atlanta

University of Colorado Anschutz Medical Campus

University of Colorado Denver

Madeline G. Huey is an author at University of North Carolina at Chapel Hill specializing in tyrosine kinase inhibitors, medicine, and oncology.

ORCID

Publications per year

2014–2021

6

Publications

6

The MERTK/FLT3 inhibitor MRX-2843 overcomes resistance-conferring FLT3 mutations in acute myeloid leukemia

Katherine A. Minson, Catherine C. Smith, Deborah DeRyckere et al. · JCI Insight · 2016 · 78 citations · Full text

, , +15

UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models

Deborah DeRyckere, Alisa B. Lee‐Sherick, Madeline G. Huey et al. · Clinical Cancer Research · 2016 · 73 citations · Full text

, , +16

MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity

Alisa B. Lee‐Sherick, Kristen M. Jacobsen, Curtis J. Henry et al. · JCI Insight · 2018 · 73 citations · Full text

, , +17

Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae

Peter M. Grace, Khara M. Ramos, Krista M. Rodgers et al. · Neuroscience · 2014 · 65 citations

, , +17

Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology

Chenxiao Da, Dehui� Zhang, Michael A. Stashko et al. · Journal of the American Chemical Society · 2019 · 20 citations · Full text

, , +17

1–5 of 6